Inhibition of autophagy enhances the selective anti-cancer activity of tigecycline to overcome drug resistance in the treatment of chronic myeloid leukemia
Crossref DOI link: https://doi.org/10.1186/s13046-017-0512-6
Published Online: 2017-03-10
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lu, Ziyuan
Xu, Na
He, Bolin
Pan, Chengyun
Lan, Yangqing
Zhou, Hongsheng
Liu, Xiaoli
Funding for this research was provided by:
Medical research foundation of Guangdong province (2015124162336427)
Science and Technology Planning Project of Guangdong Province (2014A020211019)